Dominant-negative STAT3 has been shown to reduce IL-6-induced vascular permeability associated with malignant pleural effusion in lung adenocarcinoma (Yeh et al., 2006) and decrease IgG-mediated vascular permeability during acute lung injury (Tang et al., 2011). Here, STAT3 is linked to lung adenocarcinoma.